By reducing levels of neuropeptides such as substance P (SP) and calcitonin gene-related peptide (CGRP), as well as inflammatory cytokines like tumor necrosis factor-alpha (TNF-α), bisphosphonates effectively alleviate pain in patients with osteoporosis and improve their overall quality of life. The gene discussed is TFF2; the disease is osteoporosis.